Inductively Coupled Plasma Optical Emission Spectrometer (ICP-OES) (Equipment)

The Food and Drug Administration is forecasting the procurement of an Inductively Coupled Plasma Optical Emission Spectrometer (ICP-OES). This equipment acquisition is designated as a total small business set-aside under FAR 19.5, ensuring that the opportunity is reserved for qualified small business entities. Administrative oversight for this requirement is managed by the Food and Drug Administration, with the Oc Acquisition Liaison serving as the primary program point of contact. While a specific contracting officer has not yet been named, interested parties can direct inquiries to the agency's acquisition email.